bladder cancer Veracyte Bladder Cancer Test Receives Medicare Coverage The patient must be a candidate for multiple potential treatments with varying levels of intensity or multiple therapies. OncoDiag Taking Aim at Broader Adoption of Molecular Multiplex Test for Bladder Cancer Recurrence Premium On the back of a recently announced $3 million in funding, the firm has begun marketing its Urodiag kit to urologists throughout Europe. Oncocyte AACR Data Expands Potential Applications for Immunotherapy Response Predictor The firm presented evidence that its DetermaIO gene expression test can help predict which bladder cancer patients are likely to respond to immune checkpoint inhibitors. Gene Expression Score IDs PD-1/PD-L1 Immune Checkpoint Inhibitor Resistance in Bladder Cancers Researchers said that the score further may identify patients whose treatment resistance may be overcome with combination strategies targeting certain cells. Armed With $55M in New Funding, Nucleix to Further Invest in Early-Stage Lung Cancer Dx Premium The Rehovot, Israel-based firm expects to soon receive marketing clearance from the US Food and Drug Administration for its methylation-based Bladder EpiCheck test. Mar 18, 2021 Oncocyte Details New Expansions Plans With Growing Portfolio of Acquired Tests Premium Mar 15, 2021 OncoDiag Raises $3M to Market Test for Early Detection of Recurrent Bladder Cancer Feb 26, 2021 Natera Launches Tumor Genomic Profiling Assay, Expects Reproductive Health to Break Even This Year Premium Feb 18, 2021 Qiagen, Exosome Dx Building Urine-Based Digital PCR Workflow for FGFR Mutations in Bladder Cancer Premium Dec 22, 2020 Novigenix-Led Consortium Awarded Up to €1M to Develop Predictive Immune Checkpoint Inhibitor Test Nov 6, 2020 Natera Expects Further Growth in NIPT as it Expands Use Cases for Cancer, Transplant Tests Premium Oct 12, 2020 Pacific Edge Diagnostics Receives Medicare Coverage for Bladder Cancer Test Oct 1, 2020 Cancer Clues Gleaned from Somatic Mutation Patterns in Normal Bladders Sep 9, 2020 NYGC Initiative Receives up to $2.1M for Cancer Studies in Ethnic Minorities Aug 12, 2020 GeneCentric Therapeutics, Janssen Partner to Uncover Bladder Cancer Biomarkers Aug 6, 2020 GeneCentric, Erasmus University to Research RNA Biomarkers, Therapies for Bladder Cancer May 19, 2020 Israel's Nucleix Targeting US Market With Noninvasive Bladder, Lung Cancer Assays Premium May 11, 2020 Genetic Ancestry Linked to Differences in Molecular Features of Cancers May 11, 2020 Decipher Bladder Cancer Test Determines Molecular Subtype Most Likely to Respond to Keytruda Premium Apr 6, 2020 MiR Scientific Validates Urine-Based Cancer Tests, Awaits NY State Approval Premium Jan 14, 2020 Celsee, Kindstar Ink Chinese Distribution Deal for Single-Cell Isolation Platform Dec 11, 2019 Array Genomics Sets Out to Build Business for Bladder Cancer Test Premium Nov 20, 2019 Beckman Coulter, IncellDx Form Cancer Assay Promotion Agreement Nov 5, 2019 Somatic Copy Number Changes in Normal Tissues Near Tumors Shed Light on Oncogenic Processes Oct 29, 2019 Nodexus Eyes Oncology Applications With Cancer Stem Cell Isolation, Detection Platform Premium Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.